2022 ICD-10-CM Diagnosis Code C73: Malignant Neoplasm Of ...
Toggle navigation Search All ICD-10 Toggle Dropdown
- Search All ICD-10
- ICD-10-CM Diagnosis Codes
- ICD-10-PCS Procedure Codes
- ICD-10-CM Diagnosis Index
- ICD-10-CM External Causes Index
- ICD-10-CM Table of Drugs
- ICD-10-CM Table of Neoplasms
- HCPCS Codes
- ICD-9-CM Diagnosis Codes
- ICD-9-Vol-3 Procedure Code
- Search All Data
2025
- ICD-10-CM Codes ›
- C00-D49 ›
- C73-C75 ›
- C73- ›
- 2025 ICD-10-CM Diagnosis Code C73
Malignant neoplasm of thyroid gland
- 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Billable/Specific Code
- C73 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2025 edition of ICD-10-CM C73 became effective on October 1, 2024.
- This is the American ICD-10-CM version of C73 - other international versions of ICD-10 C73 may differ.
- code to identify any functional activity
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
- C00-D49 2025 ICD-10-CM Range C00-D49
NeoplasmsNote
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
- Anaplastic thyroid carcinoma
- Cancer from the thyroid metastatic to lymph nodes of neck
- Cancer metastatic to lymph node from thyroid
- Cancer of the thyroglossal duct
- Cancer of the thyroid
- Cancer of the thyroid, anaplastic
- Cancer of the thyroid, follicular
- Cancer of the thyroid, hurthle cell
- Cancer of the thyroid, medullary
- Cancer of the thyroid, metastatic to bone
- Cancer of the thyroid, papillary
- Cancer of the thyroid, with metastasis to bilateral lungs
- Cancer of the thyroid, with metastasis to left lung
- Cancer of the thyroid, with metastasis to lungs
- Cancer of the thyroid, with metastasis to right lung
- Follicular thyroid carcinoma
- Hurthle cell carcinoma of thyroid
- Malignant tumor of thyroid gland
- Medullary thyroid carcinoma
- Papillary thyroid carcinoma
- Primary malignant neoplasm of thyroglossal duct
- Secondary malignant neoplasm of bilateral lungs from thyroid
- Secondary malignant neoplasm of left lung from thyroid
- Secondary malignant neoplasm of lungs from thyroid
- Secondary malignant neoplasm of lymph nodes from thyroid
- Secondary malignant neoplasm of lymph nodes of neck from thyroid
- Secondary malignant neoplasm of right lung from thyroid
- Thyroid cancer metastatic to bone
- Thyroid cancer metastatic to unspecified site
- A primary or metastatic malignant neoplasm affecting the thyroid gland.
- 011 Tracheostomy for face, mouth and neck diagnoses or laryngectomy with mcc
- 012 Tracheostomy for face, mouth and neck diagnoses or laryngectomy with cc
- 013 Tracheostomy for face, mouth and neck diagnoses or laryngectomy without cc/mcc
- 643 Endocrine disorders with mcc
- 644 Endocrine disorders with cc
- 645 Endocrine disorders without cc/mcc
Convert C73 to ICD-9-CM
Code History- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
- 2025 (effective 10/1/2024): No change
- Type 1 Excludes: C75 ICD-10-CM Diagnosis Code C75
Malignant neoplasm of other endocrine glands and related structures
- 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Non-Billable/Non-Specific Code
- malignant carcinoid tumors (C7A.0-)
- malignant neoplasm of adrenal gland (C74.-)
- malignant neoplasm of endocrine pancreas (C25.4)
- malignant neoplasm of islets of Langerhans (C25.4)
- malignant neoplasm of ovary (C56.-)
- malignant neoplasm of testis (C62.-)
- malignant neoplasm of thymus (C37)
- malignant neoplasm of thyroid gland (C73)
- malignant neuroendocrine tumors (C7A.-)
Diagnosis Index entries containing back-references to C73:
- Adenocarcinoma - see also Neoplasm, malignant, by site
- follicular
- with papillary C73
- moderately differentiated C73
- trabecular C73
- unspecified site C73
- well differentiated C73
- papillary
- with follicular C73
- follicular variant C73
- Hurthle cell C73
- nonencapsulated sclerosing C73
- follicular
- Carcinoma (malignant) - see also Neoplasm, by site, malignant
- C cell
- unspecified site C73
- follicular
- with papillary C73 (mixed)
- moderately differentiated C73
- pure follicle C73
- trabecular C73
- unspecified site C73
- well differentiated C73
- medullary
- with
- amyloid stroma
- unspecified site C73
- amyloid stroma
- with
- papillary
- with follicular C73 (mixed)
- follicular variant C73
- parafollicular cell
- unspecified site C73
- solid
- with amyloid stroma
- unspecified site C73
- with amyloid stroma
- Hurthle cell C73
- nonencapsulated sclerosing C73
- C cell
- Goiter (plunging) (substernal) E04.9ICD-10-CM Diagnosis Code E04.9
Nontoxic goiter, unspecified
- 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Billable/Specific Code
- Goiter NOS
- Nodular goiter (nontoxic) NOS
- cancerous C73
- malignant C73
- Hurthle cell
- adenocarcinoma C73
- carcinoma C73
- Tumor - see also Neoplasm, unspecified behavior, by site
- Hurthle cell (benign) D34ICD-10-CM Diagnosis Code D34
Benign neoplasm of thyroid gland
- 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Billable/Specific Code
- code to identify any functional activity
- malignant C73
- nonencapsulated sclerosing C73
- Hurthle cell (benign) D34ICD-10-CM Diagnosis Code D34
- Wuchernde Struma Langhans C73
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Advertise with Us | License ICD10 Data
Copyright © | ICD10data.com
Từ khóa » C73.9
-
ICD-O-3 Codes
-
C73 Malignant Neoplasm Of Thyroid Gland - ICD-10 Version:2019
-
C73 - Malignant Neoplasm Of Thyroid Gland | ICD-10-CM
-
ICD-10-Code: C73 Bösartige Neubildung Der Schilddrüse
-
Format Of ICD-O Terms In Numerical List - SEER Training
-
[PDF] Disease ICD-9 ICD-10 Thyroid Cancer 193 C73 Ischemic ... - MDPI
-
[PDF] SC73__E-ICD-10-C73-Thyroid-cancer-survival.pdf
-
Thyroid Gland: (ICD-O-3 C73.9) | Request PDF - ResearchGate